US Patent Issued to AMERICAN GENE TECHNOLOGIES INTERNATIONAL on Sept. 9 for "Methods and compositions for the activation of gamma-delta T-cells" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,446, issued on Sept. 9, was assigned to AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. (Rockville, Md.).

"Methods and compositions for the activation of gamma-delta T-cells" was invented by Charles David Pauza (Rockville, Md.), Haishan Li (Rockville, Md.), Tyler Lahusen (Rockville, Md.) and Mei-Ling Liou (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases."

The patent was filed on Nov. 1, 2022, under Application ...